Angiotensin type 2 receptor activation promotes browning of white adipose tissue and brown adipogenesis

Signal Transduction and Targeted Therapy

Volumn 2, Issue , 2017, Pages

  Than, Aung ^a   Xu, Shaohai ^a,b   Li, Ru ^a   Leow, Melvinkhee Shing ^c   Sun, Lei ^b   Chen, Peng ^a  

^a Nanyang Technological University   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85051596190     PISSN: 20959907     EISSN: 20593635     Source Type: Journal    
DOI: 10.1038/sigtrans.2017.22     Document Type: Article

References (67)

1. Basen-Engquist K, Chang M. Obesity and cancer risk: recent review and evidence. Curr Oncol Rep 2011; 13: 71–76.
2. Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 2004; 89: 2595–2600.
3. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev 2004; 84: 277–359.
4. Chondronikola M, Volpi E, Borsheim E, Porter C, Annamalai P, Enerback S et al. Brown Adipose Tissue Improves Whole Body Glucose Homeostasis and Insulin Sensitivity in Humans. Diabetes 2014; 63: 4089–4099.
5. Lidell ME, Enerback S. Brown adipose tissue–a new role in humans? Nat Rev Endocrinol 2010; 6: 319–325.
6. Harms M, Seale P. Brown and beige fat: development, function and therapeutic potential. Nat Med 2013; 19: 1252–1263.
7. Sharp LZ, Shinoda K, Ohno H, Scheel DW, Tomoda E, Ruiz L et al. Human BAT possesses molecular signatures that resemble beige/brite cells. PLoS One 2012; 7: e49452.
8. Bartelt A, Heeren J. Adipose tissue browning and metabolic health. Nat Rev Endocrinol 2014; 10: 24–36.
9. Karastergiou K, Mohamed-Ali V. The autocrine and paracrine roles of adipokines. Mol Cell Endocrinol 2010; 318: 69–78.
10. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011; 11: 85–97.
11. Sakamoto T, Takahashi N, Sawaragi Y, Naknukool S, Yu R, Goto T et al. Inflammation induced by RAW macrophages suppresses UCP1 mRNA induction via ERK activation in 10T1/2 adipocytes. Am J Physiol Cell Physiol 2013; 304: C729–C738.
12. Hui X, Gu P, Zhang J, Nie T, Pan Y, Wu D et al. Adiponectin enhances cold-induced browning of subcutaneous adipose tissue via promoting M2 macrophage proliferation. Cell Metab 2015; 22: 279–290.
13. Than A, He HL, Chua SH, Xu D, Sun L, Leow MK et al. Apelin enhances brown adipogenesis and browning of white adipocytes. JBiolChem2015; 290: 14679–14691.
14. Kalupahana NS, Moustaid-Moussa N. The renin-angiotensin system: a link between obesity, inflammation and insulin resistance. Obes Rev 2012; 13: 136–149.
15. Cassis LA, Police SB, Yiannikouris F, Thatcher SE. Local adipose tissue renin-angiotensin system. Curr Hypertens Rep 2008; 10: 93–98.
16. Engeli S, Schling P, Gorzelniak K, Boschmann M, Janke J, Ailhaud G et al. The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? Int J Biochem Cell Biol 2003; 35: 807–825.
17. Frigolet ME, Torres N, Tovar AR. The renin-angiotensin system in adipose tissue and its metabolic consequences during obesity. JNutrBiochem2013; 24: 2003–2015.
18. Than A, Leow MK, Chen P. Control of adipogenesis by the autocrine interplays between angiotensin 1-7/Mas receptor and angiotensin II/AT1 receptor signaling pathways. J Biol Chem 2013; 288: 15520–15531.
19. Zorad S, Dou JT, Benicky J, Hutanu D, Tybitanclova K, Zhou J et al. Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma. Eur J Pharmacol 2006; 552: 112–122.
20. Ohshima K, Mogi M, Jing F, Iwanami J, Tsukuda K, Min LJ et al. Direct angiotensin II type 2 receptor stimulation ameliorates insulin resistance in type 2 diabetes mice with PPARgamma activation. PLoS One 2012; 7: e48387.
21. Shum M, Pinard S, Guimond MO, Labbe SM, Roberge C, Baillargeon JP et al. Angiotensin II type 2 receptor promotes adipocyte differentiation and restores adipocyte size in high-fat/high-fructose diet-induced insulin resistance in rats. Am J Physiol Endocrinol Metab 2013; 304: E197–E210.
22. Saiki A, Ohira M, Endo K, Koide N, Oyama T, Murano T et al. Circulating angiotensin II is associated with body fat accumulation and insulin resistance in obese subjects with type 2 diabetes mellitus. Metabolism 2009; 58: 708–713.
23. Lee MJ, Wu Y, Fried SK. A modified protocol to maximize differentiation of human preadipocytes and improve metabolic phenotypes. Obesity (Silver Spring) 2012; 20: 2334–2340.
24. Araki K, Masaki T, Katsuragi I, Tanaka K, Kakuma T, Yoshimatsu H. Telmisartan prevents obesity and increases the expression of uncoupling protein 1 in diet-induced obese mice. Hypertension 2006; 48: 51–57.
25. Newsom DM, Bolgos GL, Colby L, Nemzek JA. Comparison of body surface temperature measurement and conventional methods for measuring temperature in the mouse. Contemp Top Lab Anim Sci 2004; 43: 13–18.
26. Crane JD, Mottillo EP, Farncombe TH, Morrison KM, Steinberg GR. A standardized infrared imaging technique that specifically detects UCP1-mediated thermogenesis in vivo. Mol Metab 2014; 3: 490–494.
27. Johnson I, Spence MTZ. The molecular probes handbook: a guide to fluorescent probes andlabelingtechnologies. 11th edn, Life Technologies; Carlsbad, CA, USA, 2010.
28. Than A, Zhang X, Leow MK, Poh CL, Chong SK, Chen P. Apelin attenuates oxidative stress in human adipocytes. J Biol Chem 2014; 289: 3763–3774.
29. King VL, English VL, Bharadwaj K, Cassis LA. Angiotensin II stimulates sympathetic neurotransmission to adipose tissue. Physiol Rep 2013; 1: e00014.
30. Okamatsu-Ogura Y, Fukano K, Tsubota A, Uozumi A, Terao A, Kimura K et al. Thermogenic ability of uncoupling protein 1 in beige adipocytes in mice. PLoS One 2013; 8: e84229.
31. Ohno H, Shinoda K, Spiegelman BM, Kajimura S. PPARgamma agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein. Cell Metab 2012; 15: 395–404.
32. Lopez Verrilli MA, Pirola CJ, Pascual MM, Dominici FP, Turyn D, Gironacci MM. Angiotensin-(1-7) through AT receptors mediates tyrosine hydroxylase degradation via the ubiquitin-proteasome pathway. J Neurochem 2009; 109: 326–335.
33. Walters PE, Gaspari TA, Widdop RE. Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats. Hypertension 2005; 45: 960–966.
34. Tsukuda K, Mogi M, Iwanami J, Kanno H, Nakaoka H, Wang XL et al. Enhancement of Adipocyte Browning by Angiotensin II Type 1 Receptor Blockade. PLoS One 2016; 11: e0167704.
35. Gallinat S, Busche S, Raizada MK, Sumners C. The angiotensin II type 2 receptor: an enigma with multiple variations. Am J Physiol Endocrinol Metab 2000; 278:E357–E374.
36. Steckelings UM, Rompe F, Kaschina E, Namsolleck P, Grzesiak A, Funke-Kaiser H et al. The past, present and future of angiotensin II type 2 receptor stimulation. J Renin Angiotensin Aldosterone Syst 2010; 11: 67–73.
37. Steckelings UM, Larhed M, Hallberg A, Widdop RE, Jones ES, Wallinder C et al. Non-peptide AT2-receptor agonists. Curr Opin Pharmacol 2011; 11: 187–192.
38. Fuentes P, Acuna MJ, Cifuentes M, Rojas CV. The anti-adipogenic effect of angiotensin II on human preadipose cells involves ERK1,2 activation and PPARG phosphorylation. J Endocrinol 2010; 206: 75–83.
39. Than A, Tee WT, Chen P. Apelin secretion and expression of apelin receptors in 3T3-L1 adipocytes are differentially regulated by angiotensin type 1 and type 2 receptors. Mol Cell Endocrinol 2012; 351: 296–305.
40. Dunner N, Quezada C, Berndt FA, Canovas J, Rojas CV. Angiotensin II signaling in human preadipose cells: participation of ERK1,2-dependent modulation of Akt. PLoS One 2013; 8: e75440.
41. Shiota A, Shimabukuro M, Fukuda D, Soeki T, Sato H, Uematsu E et al. Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese db/db mice. Cardiovasc Diabetol 2012; 11: 139.
42. Hwang SL, Jeong YT, Li X, Kim YD, Lu Y, Chang YC et al. Inhibitory cross-talk between the AMPK and ERK pathways mediates endoplasmic reticulum stress-induced insulin resistance in skeletal muscle. Br J Pharmacol 2013; 169: 69–81.
43. Mendoza MC, Er EE, Blenis J. The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. Trends Biochem Sci 2011; 36: 320–328.
44. Yan M, Audet-Walsh E, Manteghi S, Rosa Dufour C, Walker B, Baba M et al. Chronic AMPK activation via loss of FLCN induces functional beige adipose tissue through PGC-1alpha/ERRalpha. Genes Dev 2016; 30: 1034–1046.
45. Banks AS, McAllister FE, Camporez JP, Zushin PJ, Jurczak MJ, Laznik-Bogoslavski D et al. An ERK/Cdk5 axis controls the diabetogenic actions of PPARgamma. Nature 2015; 517: 391–395.
46. Cassis LA. Role of angiotensin II in brown adipose thermogenesis during cold acclimation. Am J Physiol 1993; 265: E860–E865.
47. Nag S, Khan MA, Samuel P, Ali Q, Hussain T. Chronic angiotensin AT2R activation prevents high-fat diet-induced adiposity and obesity in female mice independent of estrogen. Metabolism 2015; 64: 814–825.
48. Schling P. Expression of angiotensin II receptors type 1 and type 2 in human preadipose cells during differentiation. Horm Metab Res 2002; 34: 709–715.
49. Ye ZW, Wu XM, Jiang JG. Expression changes of angiotensin II pathways and bioactive mediators during human preadipocytes-visceral differentiation. Metabolism 2009; 58: 1288–1296.
50. Krauss S, Zhang CY, Lowell BB. The mitochondrial uncoupling-protein homologues. Nat Rev Mol Cell Biol 2005; 6: 248–261.
51. Gustafson B, Hammarstedt A, Hedjazifar S, Smith U. Restricted adipogenesis in hypertrophic obesity: the role of WISP2, WNT, and BMP4. Diabetes 2013; 62: 2997–3004.
52. Kurata A, Nishizawa H, Kihara S, Maeda N, Sonoda M, Okada T et al. Blockade of Angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation. Kidney Int 2006; 70: 1717–1724.
53. Nisoli E, Briscini L, Giordano A, Tonello C, Wiesbrock SM, Uysal KT et al. Tumor necrosis factor alpha mediates apoptosis of brown adipocytes and defective brown adipocyte function in obesity. Proc Natl Acad Sci USA 2000; 97: 8033–8038.
54. Gallo-Payet MS N, Baillargeon J-P, Langlois M-F, Wallinder C, Alterman M, Hallberg A et al. AT2 Receptor Agonists: Exploiting the Beneficial Arm of Ang II Signaling. Curr Hypertens Rev 2012; 8: 47–59.
55. Iwai M, Tomono Y, Inaba S, Kanno H, Senba I, Mogi M et al. AT2 receptor deficiency attenuates adipocyte differentiation and decreases adipocyte number in atherosclerotic mice. Am J Hypertens 2009; 22: 784–791.
56. Samuel P, Khan MA, Nag S, Inagami T, Hussain T. Angiotensin AT(2) receptor contributes towards gender bias in weight gain. PLoS One 2013; 8: e48425.
57. Burnett CM, Grobe JL. Direct calorimetry identifies deficiencies in respirometry for the determination of resting metabolic rate in C57Bl/6 and FVB mice. Am J Physiol Endocrinol Metab 2013; 305: E916–E924.
58. Patsouris D, Qi P, Abdullahi A, Stanojcic M, Chen P, Parousis A et al. Burn induces browning of the subcutaneous white adipose tissue in mice and humans. Cell Rep 2015; 13: 1538–1544.
59. Serazin V, Dos Santos E, Morot M, Giudicelli Y. Human adipose angiotensinogen gene expression and secretion are stimulated by cyclic AMP via increased DNA cyclic AMP responsive element binding activity. Endocrine 2004; 25: 97–104.
60. Zhang X, Zhang S, Wang C, Wang B, Guo P. Effects of moderate strength cold air exposure on blood pressure and biochemical indicators among cardiovascular and cerebrovascular patients. Int J Environ Res Public Health 2014; 11: 2472–2487.
61. Vargas F, Rodriguez-Gomez I, Vargas-Tendero P, Jimenez E, Montiel M. The renin-angiotensin system in thyroid disorders and its role in cardiovascular and renal manifestations. J Endocrinol 2012; 213: 25–36.
62. Than A, Cheng Y, Foh LC, Leow MK, Lim SC, Chuah YJ et al. Apelin inhibits adipogenesis and lipolysis through distinct molecular pathways. Mol Cell Endocrinol 2012; 362: 227–241.
63. Okada S, Kozuka C, Masuzaki H, Yasue S, Ishii-Yonemoto T, Tanaka T et al. Adipose tissue-specific dysregulation of angiotensinogen by oxidative stress in obesity. Metabolism 2010; 59: 1241–1251.
64. Siddiquee K, Hampton J, McAnally D, May L, Smith L. The apelin receptor inhibits the angiotensin II type 1 receptor via allosteric trans-inhibition. Br J Pharmacol 2013; 168: 1104–1117.
65. Hung WW, Hsieh TJ, Lin T, Chou PC, Hsiao PJ, Lin KD et al. Blockade of the renin-angiotensin system ameliorates apelin production in 3T3-L1 adipocytes. Cardiovasc Drugs Ther 2011; 25: 3–12.
66. Cassis LA, Marshall DE, Fettinger MJ, Rosenbluth B, Lodder RA. Mechanisms contributing to angiotensin II regulation of body weight. Am J Physiol 1998; 274: E867–E876.
67. Cichello SA, Weisinger RS, Schuijers J, Jois M. 1-Sarcosine-angiotensin II infusion effects on food intake, weight loss, energy expenditure, and skeletal muscle UCP3 gene expression in a rat model. J Cachexia Sarcopenia Muscle 2014; 5: 239–246.